slides · global inventory
Waterfall Chart
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 7,440
Current window 4,621-4,650
Pages 248
Rows per page 30
Tool
4,621-4,650 of 7,440
14
The chart uses a waterfall-style visualization to track program status.AbCellera | Investor Presentation Deck | 22 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
21
The chart uses a waterfall bridge structure to explain the movement of cash and securities across operating, investing, financing, and FX activities.AbCellera | Investor Presentation Deck | 22 slides · AbCellera
Conference presentation Investor relations Beat · Action1 hit
12
The chart shows a transition from negative to positive free cash flow over the five quarters presented.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · KPI OverviewLoop · Cost Of Inaction1 hit
18
The chart uses a standard waterfall bridge format to reconcile EBT to FCF.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations 1 hit
14
Includes a waterfall chart for net debt and a hierarchical diagram for capital allocation.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
05
Includes CAGR metrics and Adjusted EBITDA margin percentages.Azek | Results Presentation Deck | 21 slides · Azek
Conference presentation Investor relations 1 hit
20
Includes a footnote regarding the sale of the social card games portfolio on 28 August 2023.Azerion | Results Presentation Deck | 24 slides · Azerion
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
21
Includes a waterfall chart for CFFO and bar charts for performance and debt metrics.Azerion | Results Presentation Deck | 24 slides · Azerion
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
05
Includes footnotes explaining accounting treatment of impacts.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Loop · Logic Chain1 hit
17
Includes regulatory capital ratios and historical dividend growth.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
13
The slide uses a bar chart to show financial improvement, with a specific callout for a non-recurring tax adjustment in the Net Income chart.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations 1 hit
17
The chart uses a waterfall bridge to explain the change in cash position over the year.Deezer | Results Presentation Deck | 33 slides · Deezer
Conference presentation Investor relations 1 hit
26
The chart uses a standard waterfall bridge format to explain the change in EBITDA.Deezer | Results Presentation Deck | 33 slides · Deezer
Conference presentation Investor relations 1 hit
04
Includes a waterfall chart showing the bridge from €25.4bn in 2021 to ~€32bn in 2025.Deutsche Bank | Results Presentation Deck | 53 slides · Deutsche Bank
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
45
Includes waterfall charts for asset and liability movements and pie charts for composition.Deutsche Bank | Results Presentation Deck | 53 slides · Deutsche Bank
Conference presentation Investor relations Beat · Action1 hit
48
The chart displays quarterly averages for VaR and sVaR alongside daily Trading P&L bars.Deutsche Bank | Results Presentation Deck | 53 slides · Deutsche Bank
Conference presentation Investor relations Beat · Action1 hit
31
The chart shows a clear divergence between the treatment and placebo arms over time, with a 29.2% difference at the 180-day mark.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
32
The chart shows a divergence in SVC decline between the treatment and placebo groups over time.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations 1 hit
12
The chart illustrates the bridge between two balance sheet dates.New York Community Bancorp | Results Presentation Deck | 42 slides · New York Community Bancorp
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
37
The chart illustrates the transition from $2,088M in 2023 to $2,353M in 2024.New York Community Bancorp | Results Presentation Deck | 42 slides · New York Community Bancorp
Conference presentation Investor relations Beat · Guidance1 hit
16
Includes technical definitions of selectivity index and experimental conditions for Wistar Han rats.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
20
Clinical trial data (ALKOVE-1) showing efficacy of NVL-655 across different patient cohorts.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
32
Includes a summary table of best responses and a waterfall plot showing percentage change in target lesions by dose cohort.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
19
Slide presents two distinct clinical data visualizations: a PK line chart and a waterfall plot for mutation clearance.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
21
Clinical trial data (ALKove-1) showing efficacy of NVL-655 in NSCLC patients.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
30
Includes specific pharmacological data points for NVL-520 vs competitors like Crizotinib, Entrectinib, Lorlatinib, Taletrectinib, and Repotrectinib.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
33
Includes a summary table of ORR and best response, and a waterfall plot showing individual patient tumor regression.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
07
Includes a biological pathway diagram and a dose-response curve showing target validation.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The chart shows a bridge from $(128)M in 2022 to $30M in 2024G.P3 Health Partners | Investor Conference Presentation Deck | 19 slides · P3 Health Partners
Conference presentation Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
14
Includes adjustments for one-time items and 1st quarter earnings breakdowns.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit